| Swetha Dhanireddy, MD | |
|
7900 Rollins Rd Ste B1300, Gurnee, IL 60031-1512 | |
| (224) 251-2020 | |
| (224) 251-2010 |
| Full Name | Swetha Dhanireddy |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 7900 Rollins Rd Ste B1300, Gurnee, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659753960 | NPI | - | NPPES |
| 0006713 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 35147038 (Ohio) | Secondary |
| 207W00000X | Ophthalmology | 036163372 (Illinois) | Primary |
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
The Stroke Association warned today against the hidden dangers from the high levels of salt, sugar and fat found in many popular breakfast cereals enjoyed by both children and adults.
Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
Building on the evidence-based findings of five previously published guidelines of care that examine the use of a variety of medical therapies for the management and treatment of psoriasis and psoriatic arthritis, the American Academy of Dermatology has released its sixth and final guidelines of care for psoriasis.
› Verified 3 days ago
| Entity Name | Osu Eye Physicians And Surgeons, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861437923 PECOS PAC ID: 5698671881 Enrollment ID: O20230213000139 |
News Archive
The Stroke Association warned today against the hidden dangers from the high levels of salt, sugar and fat found in many popular breakfast cereals enjoyed by both children and adults.
Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
Building on the evidence-based findings of five previously published guidelines of care that examine the use of a variety of medical therapies for the management and treatment of psoriasis and psoriatic arthritis, the American Academy of Dermatology has released its sixth and final guidelines of care for psoriasis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Swetha Dhanireddy, MD 7900 Rollins Rd Ste B1300, Gurnee, IL 60031-1512 Ph: (224) 251-2020 | Swetha Dhanireddy, MD 7900 Rollins Rd Ste B1300, Gurnee, IL 60031-1512 Ph: (224) 251-2020 |
News Archive
The Stroke Association warned today against the hidden dangers from the high levels of salt, sugar and fat found in many popular breakfast cereals enjoyed by both children and adults.
Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life.
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
Building on the evidence-based findings of five previously published guidelines of care that examine the use of a variety of medical therapies for the management and treatment of psoriasis and psoriatic arthritis, the American Academy of Dermatology has released its sixth and final guidelines of care for psoriasis.
› Verified 3 days ago
Dr. Steven D Reinglass, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 310 S Greenleaf St Ste 209, Gurnee, IL 60031 Phone: 847-244-1657 Fax: 847-244-5122 | |
Dr. Nancy Anderson Hamming, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 48 S Greenleaf St, Gurnee, IL 60031 Phone: 847-662-4016 Fax: 847-662-4174 | |
Rebekah Arletta Braslow, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7900 Rollins Rd Ste B1300, Gurnee, IL 60031 Phone: 224-251-2020 | |
Dr. Daniel Joseph Green, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 48 S Greenleaf St, Gurnee, IL 60031 Phone: 847-668-4016 Fax: 847-662-4174 | |
Dr. Rachael A Greenberg, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 48 S Greenleaf St, Gurnee, IL 60031 Phone: 847-662-4016 Fax: 847-662-4174 | |
Dr. Walter I Fried, PH.D., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3477 Grand Ave, Gurnee, IL 60031 Phone: 847-249-4660 Fax: 847-249-4950 |